Farther Finance Advisors
ATYR icon

Farther Finance Advisors’s aTyr Pharma ATYR Stock Holding History

Farther Finance Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35 Sell
115
-257
-69% -$125 ﹤0.01% 6041
2026
Q2 		$222 Sell
372
-948
-72% -$619 ﹤0.01% 5702
2026
Q1 		$1.12K Sell
1,320
-905
-41% -$764 ﹤0.01% 5078
2025
Q4 		$1.74K Buy
2,225
+125
+6% +$103 ﹤0.01% 4743
2025
Q3 		$1.51K Sell
2,100
-17,823
-89% -$80.8K ﹤0.01% 4237
2025
Q2 		$101K Sell
19,923
-4,500
-18% -$17.7K ﹤0.01% 1760
2025
Q1 		$70.3K Hold
24,423
– – ﹤0.01% 1705
2024
Q4 		$88.4K Sell
24,423
-9,000
-27% -$27.3K ﹤0.01% 1359
2024
Q3 		$58.8K Buy
33,423
+3,000
+10% +$5.46K ﹤0.01% 1564
2024
Q2 		$47.5K Buy
30,423
+100
+0.3% +$174 ﹤0.01% 1443
2024
Q1 		$57.9K Hold
30,323
– – ﹤0.01% 1131
2023
Q4 		$42.8K Buy
+30,323
New +$38.9K ﹤0.01% 1093

Other funds holding ATYR

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors's ATYR Position: Q3 2026 in Review

Farther Finance Advisors reduced its aTyr Pharma (ATYR) stake by 69% in Q3 2026, selling an estimated $125 and leaving 115 shares worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #6041.

Farther Finance Advisors first reported a position in ATYR in Q4 2023 and has held it in 12 quarters since. The position peaked at $101K in Q2 2025. 4 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

  • Farther Finance Advisors held 115 shares of aTyr Pharma worth $35 as of Q3 2026.
  • Farther Finance Advisors sold 257 aTyr Pharma shares in Q3 2026, an estimated $125.
  • aTyr Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6041 holding.
  • Farther Finance Advisors first reported a position in aTyr Pharma in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's aTyr Pharma position peaked at $101K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.